EDCTP will host a webinar from18-19 March to share experiences and study findings from EDCTP-supported COVID-19 research consortia, with a specific focus upon sub-Saharan Africa. Register here: edctp.org/event/webinar-…. zoom.us/webinar/regist….

All AMBITION participants have now completed 16-week follow-up; well done to all our study teams! Watch this space...

Delighted to announce that David Lawrence will present the results of the AMBITION Phase III trial on behalf of the consortium at IAS Conference on HIV Science (Inactive account) on Wednesday 21 July, 10am CET during the Track B late-breaker oral abstract session. We hope you will be able to join remotely.

All are welcome to the Pre-IAS Webinar on Cryptococcal Meningitis and Access to Treatment this Thursday 15 July, 14h00 CET. Register at the link below: us02web.zoom.us/meeting/regist…

Thrilled to report primary outcome of AMBITION-cm trial. Single, high-dose LAmB with 14 days 5FC + fluconazole non-inferior to WHO recommended SOC (7 days AmB + 5FC then 7 days fluco). LAmB mortality 24.8% vs 28.7% in control. Full results IAS Conference on HIV Science (Inactive account) Wednesday 21st 10:00 CET

theprogramme.ias2021.org/Abstract/Abstr… IAS Conference on HIV Science (Inactive account) Mina

Delighted to see a number of articles and press releases published following David Lawrence's recent IAS presentation: MSF: msf.org.za/news-and-resou… AIDSMAP: aidsmap.com/news/jul-2021/… Medscape: medscape.com/viewarticle/95… Gilead: gilead.com/news-and-press…

Two more pieces on the AMBITION results following David Lawrence's IAS presentation in July, this time published by touchINFECTIOUSDISEASES: touchinfectiousdiseases.com/hiv/conference… touchinfectiousdiseases.com/hiv/conference…

Pleased to see that David Lawrence's video presentation of the AMBITION results at IAS 2021 is now fully accessible online - no need for an IAS registration login. Watch it here: theprogramme.ias2021.org/Programme/Sess…

*Online course in Medical Mycology* - our colleagues at INSTITUT PASTEUR will be delivering an 11-week course, in English (with French subtitles), starting 1 Oct 2021. Registration FREE, with a certificate available for a small fee. Please share widely. fun-mooc.fr/en/courses/med…

Reminder: registration still open (and free!) for the virtual EDCTP Forum, 17-21 October: edctpforum.eventsair.com/edctp-forum-20…. Don't miss the short talk by David Lawrence on the LEOPARD social science sub-study from the AMBITION trial on the Tuesday afternoon: az659834.vo.msecnd.net/eventsairweste…

We extend our warmest congratulations to Professor Graeme Meintjes on winning the 2020 Scientific Leadership Prize! #EDCTPForum

Thanks to EDCTP for funding AMBITION Study and for your commitment to CM and advanced HIV disease. Such a wonderful funder and an incredible range of important projects supported #WAD2021

Great to see the commitment to rapid implementation of the single, high-dose regimen which is the new first-line for cryptococcal meningitis in Zimbabwe

Job opportunity with ⁦MSF International⁩ in Cape Town. Part-time Principal Investigator of AMBI-ONE implementation study of ⁦AMBITION Study⁩ regimen in DRC, Guinea & Mozambique. Possible scope to enhance to full-time PhD fellowship ⁦Wits University⁩ msfsa.bamboohr.com/careers/266

Social Science PhD Fellowship Opportunity! Come and work Wits University alongside myself and Nelesh Govender on exciting work around advanced HIV disease and cryptococcal infection within the EFFECT Trial - applications close on 17th November, DM with questions bitly.ws/ZeJu

Are you involved in #HIV #advocacy? Interested in the latest research? In the run up to #WAD2023 come and hear about recent advances in HIV-associated cryptococcal meningitis at our CSO briefing webinar. Monday 27th November - see flyer and register here: bitly.ws/ZXAM